Zobrazeno 1 - 10
of 13
pro vyhledávání: '"L F, Massuger"'
Publikováno v:
European journal of gynaecological oncology. 22(6)
The purpose of the present study was to determine the gluthathione S-transferases (GST) P1-1 and A1-1 levels in cyst fluid from malignant, borderline, and benign ovarian tumors. The clinical relevance of these enzymes in cyst fluid was investigated,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0760f76e083aad4dca7602cc7c78f331
https://pubmed.ncbi.nlm.nih.gov/11874074
https://pubmed.ncbi.nlm.nih.gov/11874074
Publikováno v:
Cancer. 91(2)
The purpose of the current study was to determine vascular endothelial growth factor (VEGF) concentrations in cyst fluid from malignant, borderline, and benign ovarian tumors, and to correlate these data with preoperative serum VEGF concentrations an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::46221b00c8b43a49c18f40f860517deb
https://pubmed.ncbi.nlm.nih.gov/11180084
https://pubmed.ncbi.nlm.nih.gov/11180084
Autor:
E A, Boss, S H, Moolenaar, L F, Massuger, H, Boonstra, U F, Engelke, J G, de Jong, R A, Wevers
Publikováno v:
NMR in biomedicine. 13(5)
Most ovarian tumors are cystic structures containing variable amounts of fluid. Several studies of ovarian cyst fluid focus on one specific metabolite using conventional assay systems. We examined the potential of (1)H-nuclear magnetic resonance spec
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2639b5199dfb7265ee29662820011586
https://pubmed.ncbi.nlm.nih.gov/10960920
https://pubmed.ncbi.nlm.nih.gov/10960920
Publikováno v:
Anticancer research. 18(3B)
Most studies evaluating the role of serum CA 125 measurements in endometrial cancer report a positive correlation with prognostic factors. The present study investigates the role of serum CA 125 measurements as a preoperative aid in the decision whet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e7c3dfd346c932c3fc5c90acbc726dca
https://pubmed.ncbi.nlm.nih.gov/9677441
https://pubmed.ncbi.nlm.nih.gov/9677441
Publikováno v:
Cancer. 82(9)
Currently used techniques such as ultrasound, computed tomography, and magnetic resonance imaging are not fully capable of differentiating benign from malignant ovarian tumors. Magnetic resonance spectroscopy (MRS) may help solve this clinical proble
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::e9a1c7255ba848acdd49ed15d76edc5a
https://pubmed.ncbi.nlm.nih.gov/9576295
https://pubmed.ncbi.nlm.nih.gov/9576295
Publikováno v:
European journal of clinical chemistry and clinical biochemistry : journal of the Forum of European Clinical Chemistry Societies. 35(8)
Clinical management of ovarian cancer patients is facilitated by CA 125 determinations in serum. Presently, several assay systems based on different concepts and different methodologies are available to measure CA 125. Method comparison analysis of s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4d0bb251e5bbd38aa7cd562482c36921
https://pubmed.ncbi.nlm.nih.gov/9746276
https://pubmed.ncbi.nlm.nih.gov/9746276
Publikováno v:
International journal of cancer. 66(4)
The bispecific monoclonal antibody (biMAb) OC/TR combines the anti-ovarian-cancer reactivity of the MOv18 monoclonal antibody (MAb) with the reactivity of an anti-CD3 MAb. Pre-clinical studies have indicated that this biMAb is able to redirect the cy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f541240eb81db72d78d4994abea79761
https://pubmed.ncbi.nlm.nih.gov/8635863
https://pubmed.ncbi.nlm.nih.gov/8635863
Publikováno v:
Anticancer research. 15(5B)
The anti-tumour x anti-T-cell bispecific monoclonal antibody (biMAb) OC/TR is a biologically produced biMAb combining the anti-ovarian carcinoma activity of the MOv18 MAb with anti-CD3/T-cell receptor (TCR) complex activity. In this study, the in vit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ccba2bd342ea880a13f688a0d87474c0
https://pubmed.ncbi.nlm.nih.gov/8572619
https://pubmed.ncbi.nlm.nih.gov/8572619
Publikováno v:
Clinical chemistry. 41(2)
We compared the improved Abbott IMx cancer antigen (CA) 125 assay (cat. no. 7A89) with the Abbott CA 125 RIA. Serum specimens were from healthy perimenopausal women (n = 124) and from patients with benign gynecologic and nongynecologic diseases (n =
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::4f1fe0126452da40fb3576a3fd4c7a52
https://pubmed.ncbi.nlm.nih.gov/7874773
https://pubmed.ncbi.nlm.nih.gov/7874773
Autor:
L F, Massuger, C M, Thomas, M F, Segers, F H, Corstens, R H, Verheijen, P, Kenemans, L G, Poels
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 33(11)
The development of human anti-mouse antibodies (HAMA) may cause problems in radioimmunotargeting studies, but may also improve survival of patients. To identify the presence of HAMA in blood samples from patients intravenously injected with 1 mg of 1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::1a5105dad1856b31de59edd6c32b7934
https://pubmed.ncbi.nlm.nih.gov/1432156
https://pubmed.ncbi.nlm.nih.gov/1432156